Ventas, Inc.
A $47B healthcare REIT owning senior housing, medical offices, and hospitals.
Ventas's growth now depends on senior housing occupancy and rates, not fixed rent checks, making results more exposed to demand and labor costs.
Ventas is a real estate company that owns nursing homes, senior housing, and medical offices across the United States and rents them to operators or runs them directly. It is difficult to copy quickly because it took decades to build relationships with 43 long-term operating partners, it holds healthcare licenses tied to specific locations, and it knows how each property runs from years of data; artificial intelligence tools like the NIC MAP Vision suite that were released in early 2024 are sold to Ventas to help it manage better, not to replace owning the buildings themselves. The main risk is that Ventas recently shifted from collecting steady rent checks to running properties directly, which means it now faces rising labor costs and must keep beds full; if interest rates stay high when Ventas refinances loans in mid-2026, its profits could drop noticeably.
Ventas misses its guided $2.5-3B 2026 senior housing acquisition pipeline. Would show Welltower or other bidders are winning deal flow and operator relationships instead.
Q2 2026 earnings on July 29, 2026 show FFO growth or guidance cut below the $3.82-3.89 range. Would show rate pressure or SHOP execution problems are hitting profitability harder than expected.
- SHOP Same-Store NOI grew over 15% in FY2025
- 43 operator partners, up from 10 in 2020
- $2.5-3B senior housing acquisitions targeted for 2026
- Rising interest rates could compress FFO growth and increase refinance costs in 2026.
- Shift to 53% SHOP NOI exposure by Q4 2025 increases sensitivity to occupancy, RevPOR, and labor costs versus fixed rent.
- 2026 pipeline target of $2.5-3B in acquisitions could miss if deal flow or yields disappoint.
- Surge in new senior-housing construction could undercut the supply-constraint bull thesis.
- Mixed analyst price target moves (Scotiabank cut to $88, Deutsche Bank raised to $100) signal repricing uncertainty ahead of July 2026 earnings.
| Rival | Direction | Evidence |
|---|---|---|
| Welltower Inc. | contesting | Welltower ~$138-163B market cap vs Ventas ~$47B, both riding same demographic tailwind as of July 2026 |
| Healthpeak Properties | gaining on | Ventas SHOP NOI growth of 15.4% and TSR over 35% in 2025 outpaces smaller ~$14-15B peer per June 2026 analysis |
| Omega Healthcare Investors | contesting | Omega ~$14-15B market cap, skilled nursing focus, smaller scale than Ventas as of June 2026 |
| NIC MAP Vision (AI vendor) | contesting | Third-party AI analytics suite launched March 2024, sold as tool to REITs including potentially Ventas, not a direct competitor to asset ownership |
- Is Ventas, Inc. profitable in 2026?
- Ventas reported FY2025 normalized FFO per share of $3.48, up 9% YoY, with 2026 guidance raised to $3.82-$3.89 per share as of February 2026, alongside FY2025 revenue of $5.79 billion, up roughly 18.5-21% YoY.
- Could AI replace Ventas's core business?
- No. Ventas's moat is 1,400+ owned properties, 43 operator relationships, and healthcare licensing as of Q1 2026. Third-party NIC MAP Vision launched an AI analytics suite in March 2024, but it is a vendor tool sold to REITs, not a substitute for physical asset ownership.
- Who is Ventas's biggest competitor?
- Welltower Inc. (WELL) is Ventas's largest competitor, with a market cap of roughly $138-163 billion and 2,400+ properties as of July 2026, versus Ventas's ~$47 billion market cap and 1,400+ properties, per Big Three healthcare REIT analysis dated June 2026.
- Who owns Ventas, Inc.?
- Ventas is a fully public company listed on the NYSE under ticker VTR as part of the S&P 500, as of July 2026. Insider ownership is low at roughly 0.53% per recent SEC-disclosed insider trades, with no parent company or pending acquisition identified.
- Is Ventas losing market share to Welltower?
- No clear evidence of share loss as of July 2026. Both REITs benefit from the same demographic tailwind (U.S. 80+ population up 55% by 2035), and Ventas posted 2025 SHOP Same-Store NOI growth of over 15% and total shareholder return above 35%, per June 2026 peer analysis.
- What is Ventas's exposure to interest rate risk in 2026?
- Ventas shifted from 31% SHOP NOI in Q4 2021 to 53% SHOP NOI by Q4 2025, exposing it more to occupancy, rate, and labor costs than fixed rent. Analysts flagged higher interest expense as a headwind ahead of Q2 2026 earnings on July 29, 2026.
- 2026-07-29Ventas Q2 2026 earnings release scheduled, conference call July 30
- 2026-06Andrew L. Wattula appointed EVP, Outpatient Medical & Research
- 2026-04-28Q1 2026 earnings call reports $540M Revel senior housing portfolio deal
- 2026-03-31Portfolio reaches 1,400+ properties, 43 operating partners, 96,000+ seniors served
- 2026-02-05FY2025 results: $5.79B revenue, FFO $3.48/share, SHOP NOI +15%
- 2026-02-01Dividend raised 8% to $0.52 per quarter
- 2025-12-31Net debt-to-EBITDA improves to 5.2x from 6.0x; 542 corporate employees
- 2025-05Stockholders approve doubling authorized shares from 600M to 1.2B
- 2024-03NIC MAP Vision launches AI suite for senior-housing market analysis
- Here's What to Expect From Ventas' Next Earnings Report (2026-07-07)
- gurufocus.com (2026-07-24)
- Ventas Inc. financials, VectorShift Research (2026-06-25)
- Ventas (VTR) Revenue 2005-2026 (2026-06-22)
- What's in the Offing for Ventas Stock This Earnings Season? (2026-07-23)
- Ventas Reports Fourth Quarter and Full Year 2025 Results (2026-02-05)
- Senior housing drives 10% FFO growth, strong 2026 outlook (2026-02-06)
- Senior Housing (2026-03-30)
- Ventas VTR Q1 2026 Earnings Call Transcript (2026-04-28)
- Ventas, Inc. SEC 10-K Report (2026-02-06)
- Ventas (VTR) Number of Employees 1998-2025 (2026-07-16)
- NIC MAP Vision launches first-of-its-kind AI suite